[HTML][HTML] MicroRNAs as new biomarkers for diagnosis and prognosis, and as potential therapeutic targets in acute myeloid leukemia

S Trino, D Lamorte, A Caivano, I Laurenzana… - International journal of …, 2018 - mdpi.com
Acute myeloid leukemias (AML) are clonal disorders of hematopoietic progenitor cells which
are characterized by relevant heterogeneity in terms of phenotypic, genotypic, and clinical …

[HTML][HTML] Remodeling the epigenetic landscape of cancer—application potential of flavonoids in the prevention and treatment of cancer

W Jiang, T Xia, C Liu, J Li, W Zhang, C Sun - Frontiers in Oncology, 2021 - frontiersin.org
Epigenetics, including DNA methylation, histone modification, and noncoding RNA
regulation, are physiological regulatory changes that affect gene expression without …

Evaluation of co-fermentation of L. plantarum and P. kluyveri of a plant-based fermented beverage: Physicochemical, functional, and sensory properties

H Liu, Y Ni, Q Yu, L Fan - Food Research International, 2023 - Elsevier
In this study, Pichia kluyveri (P. kluyveri) and Lactobacillus plantarum (L. plantarum) were
sequentially inoculated into a plant-based beverage consisting of bananas, broccoli, and …

[HTML][HTML] RETRACTED ARTICLE: Aberrant mannosylation profile and FTX/miR-342/ALG3-axis contribute to development of drug resistance in acute myeloid leukemia

B Liu, X Ma, Q Liu, Y Xiao, S Pan, L Jia - Cell death & disease, 2018 - nature.com
Drug-resistance is a major problem in acute myeloid leukemia (AML) chemotherapy.
Aberrant changes in specific N-glycans have been observed in leukemia multidrug …

Clinical significance of circulatory microRNA-203 in serum as novel potential diagnostic marker for multiple myeloma

N Gupta, R Kumar, T Seth, B Garg, HC Sati… - Journal of Cancer …, 2019 - Springer
Purpose Multiple myeloma (MM) is a hematological malignancy marked by uncontrolled
proliferation and accumulation of plasma cells in bone marrow. Despite presence of …

Comprehensive analysis of circulating miRNAs in the plasma of patients with pituitary adenomas

K Németh, O Darvasi, I Likó, N Szücs… - The Journal of …, 2019 - academic.oup.com
Background Circulating miRNAs in pituitary adenomas would improve patient care,
especially as minimally invasive biomarkers of tumor recurrence and progression in …

[HTML][HTML] MiR-92a family: a novel diagnostic biomarker and potential therapeutic target in human cancers

M Jiang, X Li, X Quan, X Li, B Zhou - Frontiers in molecular …, 2019 - frontiersin.org
Purpose: This study tried to explore whether members of miR-92a family contribute to early
diagnosis and prognosis for human cancers and how they work. Methods: Integrated meta …

Exosomal miR‐122, miR‐128, miR‐200, miR‐298, and miR‐342 as novel diagnostic biomarkers in NAFL/NASH: Impact of LPS/TLR‐4/FoxO3 pathway

AM Samy, MA Kandeil, D Sabry… - Archiv der …, 2024 - Wiley Online Library
Nonalcoholic fatty liver disease (NAFLD) is a common liver disorder affecting a quarter of the
global residents. Progression of NAFL into nonalcoholic steatohepatitis (NASH) may cause …

[HTML][HTML] Exosomal miR92a promotes cytarabine resistance in myelodysplastic syndromes by activating Wnt/β-catenin signal pathway

H Li, C Xie, Y Lu, K Chang, F Guan, X Li - Biomolecules, 2022 - mdpi.com
Cytarabine (Ara-C) has been one of the frontline therapies for clonal hematopoietic stem cell
disorders, such as myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML), but …

[HTML][HTML] Identification of endogenous control miRNAs for RT-qPCR in T-cell acute lymphoblastic leukemia

M Drobna, B Szarzyńska-Zawadzka… - International journal of …, 2018 - mdpi.com
Optimal endogenous controls enable reliable normalization of microRNA (miRNA)
expression in reverse-transcription quantitative PCR (RT-qPCR). This is particularly …